A Hard Lesson on Building in Chile

Related Link: 

Last August, Chilean billionaire Horst Paulmann completed what he expected to be a crowning achievement of his business career: South America’s tallest building. But the development is turning into a black eye.

Ailing Travelers CEO Fishman to Exit

Related Link: 

Jay S. Fishman is stepping down Dec. 1, handing over his job to Alan D. Schnitzer, who runs the company’s largest segment.

GM to Upgrade Flint, Mich., Plant

Related Link: 

General Motors will spend $877 million to upgrade a truck factory in Flint, Mich., amid solid demand for the auto maker’s Chevrolet and GMC full-size pickups.

Don't Bank on Freddie's Guarantee

Related Link: 

Freddie Mac’s big profit masked small earnings in its core business.

Bird in Regeneron's Hand Is Enough

Related Link: 

Strong Eylea sales sent Regeneron stock—and future expectations—ever higher.

Paring Sprint's Subscriber Gains

Related Link: 

Sprint’s fiscal first-quarter results showed better subscriber numbers and churn, but the company’s fundamental challenges remain.

Shire's Blind Test With Baxalta

Related Link: 

Shire is venturing into bigger, riskier deal making with its $31 billion unsolicited bid to buy U.S. biotech Baxalta.

Chesapeake Energy's Moody Shareholders

Related Link: 

The market’s reaction to Chesapeake Energy’s dividend cut has provided a buying opportunity and potentially makes the company attractive to an acquirer.

Judge Rejects Proposed Settlement Between AmEx and Merchants

Related Link: 

A federal judge rejected a proposed $79 million class-action settlement between American Express and a group of merchants, citing a recent discovery that two opposing lawyers in the case had exchanged confidential documents.

Shire Mounts $30.6 Billion Bid for Biotech

Related Link: 

Shire made an unsolicited $30.6 billion offer for rare-disease treatment maker Baxalta, becoming the latest deal-hungry company refusing to take “no” for an answer amid the current deal boom.

Syndicate content